Celiac

Investor type

VC

Founded

1990

AUM

$15 M

Location

Los Angeles, California, United States

$10-50 m

Investment Ticket

3-5 years

Investment Horizon

Pre-seed, Seed

Investment Stage

IPO, M&A

Exit Strategy

Investor profile last updated: 27 July, 2026

Profile

Celiac disease is one of the world’s most prevalent genetic autoimmune diseases, affecting an estimated 3 million Americans, 70-80% of whom are undiagnosed. Causing the body to attack its own small intestine, it can lead to many other devastating health conditions, including cancer. Unfortunately for the millions who suffer, celiac disease has largely been ignored by our federal government which provides little to no funding for research nor for public awareness of its serious consequences. Through strategic investments in research, education, and advocacy, the Celiac Disease Foundation seeks to remedy this by accelerating treatments and a cure.

The Celiac Disease Foundation, established in 1990, is a leading global patient advocacy organization committed to accelerating diagnosis, treatments, and a cure for celiac disease. Our mission is to improve the health and well-being of the millions of individuals around the world affected by this genetic autoimmune disease through our strategic investments in research, advocacy, and education. Our iCureCeliac® patient registry and extensive patient recruitment services enable us to identify qualified patient candidates and speed their enrollment to advance critical disease research. Our unparalleled advocacy program has led the way to secure federal recognition and first-ever research funding from agencies including the U.S. National Institutes of Health and the Department of Defense. We adhere to the highest scientific and ethical standards as we work each day to promote understanding of celiac disease, empower our patient and provider community, and collaborate with partners and stakeholders to carry our mission forward.

Industry

Biotechnology Business Services (B2B) Digital Healthcare Services HealthTech Medical Devices Life Sciences

Region of investment

North America

Celiac Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Celiac Disease Foundation Impact Fund
Venture Capital (VC)
Biotechnology
Healthcare Services
Medical Devices
Life Sciences
Pre-seed
Seed
North America
$5-10 m
$15 M
March 2026

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
QCSUaK5x4Vrclj9E QCSUaK5x4Vrclj9E
QCSUaK5x4Vrclj9E
avatar
QCSUaK5x4Vrclj9E QCSUaK5x4Vrclj9E
QCSUaK5x4Vrclj9E
avatar
QCSUaK5x4Vrclj9E QCSUaK5x4Vrclj9E
QCSUaK5x4Vrclj9E
avatar
QCSUaK5x4Vrclj9E QCSUaK5x4Vrclj9E
QCSUaK5x4Vrclj9E
avatar
QCSUaK5x4Vrclj9E QCSUaK5x4Vrclj9E
QCSUaK5x4Vrclj9E
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!

FAQs about Celiac

Celiac is located in Los Angeles, California, United States.
Celiac was founded in 1990.
Celiac invests in companies and startups in Biotechnology, Business Services (B2B), Digital, Healthcare Services, HealthTech, Medical Devices, Life Sciences.
Celiac invests in companies and startups in North America.
Celiac invests in companies and startups at Pre-seed, Seed.
Celiac usually invests $10-50 m on average.
Celiac has around $15m assets under management.
Celiac last fund was created/launched in 2026-03-18